Research News

  • UVM Medical Center & Vaccine Testing Center Complete COVID-19 Vaccine Trial Enrollment
    The UVM Medical Center and Vaccine Testing Center have successfully reached and surpassed the targeted number of enrollees for an ongoing Phase 3 clinical trial of the AstraZeneca COVID-19 vaccine.
  • Copeland Study Evaluates College Student Wellness in a Pandemic
    A study by UVM faculty members published in the Journal of the American Academy of Child and Adolescent Psychiatry reports that in a group of first-year university students, COVID-19 mitigation protocols had a modest, but persistent, impact on mood and wellness behaviors. Students enrolled in the university's wellness program, however, had improved mood levels and fewer attention problems.
  • Plante & Colleagues' Study Details First AI Tool to Help Labs Rule-Out COVID-19
    A recent study conducted by collaborators from the University of Vermont and Cedars-Sinai describes the performance of South Burlington, Vt.-based Biocogniv’s new AI-COVID™ software.
  • Francklyn Among Three UVM Scientists Named AAAS Fellows
    Three University of Vermont professors, include Professor of Biochemistry Christopher Francklyn, Ph.D., have been named Fellows of the American Association for the Advancement of Science (AAAS), the world’s largest multidisciplinary scientific society, for their outstanding contributions to science.
  • Larner Faculty Inducted into Vermont Academy of Science and Engineering
    The Vermont Academy of Science and Engineering formally inducted Larner College of Medicine Dean and Professor of Medicine Richard L. Page, M.D., Professor of Pharmacology Frances Carr, Ph.D., and Professor of Biochemistry Christopher Francklyn, Ph.D., at the Academy's annual meeting on October 26, 2020.
  • Lee & Hebert-Dufresne Publish SARS-CoV-2 Transmission Model for School Opening
    Can schools safely remain open or reopen during periods of significant community spread of COVID-19? According to predictions from a UVM model of SARS-CoV-2 transmission in the school setting, yes – if appropriate precautions are followed both in school and in the community.
  • Villanti, Copeland Named to List of World’s Most Influential Researchers
    UVM faculty members Andrea Villanti, Ph.D., M.P.H., associate professor of psychiatry, and William Copeland, Ph.D., professor of psychiatry, have been named to a list of the world’s most influential researchers - the Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.
  • Weiss Receives ALA Grant to Study COVID-19 Lung Damage
    University of Vermont Professor of Medicine Daniel Weiss, M.D., Ph.D., has been selected to receive one of the inaugural American Lung Association COVID-19 Action Initiative's COVID-19 and Respiratory Virus Research Award.
  • Research Excellence Highlighted at Fifth Annual Celebration
    The Larner College of Medicine hosted the fifth annual "Dean's Celebration of Excellence in Research" on November 4 and 5. The two-day event highlighted the research being conducted by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
  • Study Finds Lowering Nicotine Reduces Smoking Addictiveness in Vulnerable Populations
    A JAMA Network Open study, led by Stephen T. Higgins, Ph.D., director of the Vermont Center on Behavior and Health at the University of Vermont’s Larner College of Medicine, provides evidence that, even in smokers from vulnerable populations, reducing nicotine content to low levels decreases addictiveness – a timely finding as the Food and Drug Administration (FDA) considers a policy to lower nicotine content in all cigarettes sold in the U.S.